Skip to Content

One Bio Corp ONBI

Morningstar Rating
$0.00 0.00 (40.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ONBI is trading at a 37% discount.
Price
$0.00
Fair Value
$3.41
Uncertainty
Extreme
1-Star Price
$8.28
5-Star Price
$9.82
Economic Moat
Dzppcf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ONBI is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$25,412.05
Volume/Avg
5,764 / 5,764

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

One Bio Corp utilizes green processes to produce raw chemicals and herbal extracts, natural supplements and organic products. It is focused on the growing Asia Pacific region to deliver organic and acquisition driven growth.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
358

Valuation

Metric
ONBI
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ONBI
Quick Ratio
1.14
Current Ratio
1.57
Interest Coverage
10.61
Quick Ratio
No chart available

Profitability

Metric
ONBI
Return on Assets (Normalized)
12.35%
Return on Equity (Normalized)
21.07%
Return on Invested Capital (Normalized)
15.10%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRZrwb$531.9 Bil
VRTX
Vertex Pharmaceuticals IncHkfdk$108.7 Bil
REGN
Regeneron Pharmaceuticals IncLkslwg$106.0 Bil
MRNA
Moderna IncGtffb$35.2 Bil
ARGX
argenx SE ADRGhnf$22.1 Bil
BNTX
BioNTech SE ADRYgqw$21.1 Bil
ALNY
Alnylam Pharmaceuticals IncJqfxc$19.0 Bil
BMRN
Biomarin Pharmaceutical IncSpvsbmd$16.3 Bil
RPRX
Royalty Pharma PLC Class ALjhpxy$13.6 Bil
INCY
Incyte CorpSbvnhkk$13.1 Bil

Sponsor Center